
Opinion|Videos|July 23, 2024
Optimizing Therapy Sequencing in CLL
A panel of experts discuss optimizing therapy sequencing in CLL.
Advertisement
Episodes in this series

Video content above is prompted by the following question(s):
- How do you determine the optimal sequencing of therapies for patients with CLL?
- How does prior therapy exposure influence your choice of subsequent treatments?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer
2
How Artificial Intelligence Is Transforming Leukemia Detection and Diagnosis
3
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
4
FDA Approves Sibeprenlimab for Immunoglobulin A Nephropathy
5













































